EMMAUS LIFE SCIENCES, INC. (EMMA)

Every figure this model derived for EMMA, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 1,000 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 29,815,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 6,003,000 AssetsCurrent 2026-06-30
current liabilities 66,116,000 LiabilitiesCurrent 2026-06-30
equity -66,176,000 StockholdersEquity 2026-06-30
interest expense 7,922,000 InterestExpense 2026-06-30
ocf -11,000 NetCashProvidedByUsedInOperatingActivities 2025-12-31
revenue 15,530,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 17,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up EMMA on one particular measure came for.

RatioValue
cash operating margin29.78
current ratio0.09
current ratio reported0.09
dilution pct1.27
fcf margin-0.08
interest cover0.57
operating margin29.29
owner earnings margin-0.19
revenue growth10.98
revenue growth per share9.59
rule of 4040.28
sbc pct revenue0.11

What to be careful about

What this model itself distrusts about EMMA's figures. Written by the derivation as it ran, not added afterwards.